Clinical Trial: A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Cannabidiol Capsules (AVAT-121) and Epidyolex(R) in Healthy Adults

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918469) titled 'A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Cannabidiol Capsules (AVAT-121) and Epidyolex(R) in Healthy Adults' on Nov. 01.

Brief Summary: This Phase 1 study will evaluate the safety, tolerability, and pharmacokinetics of AVAT-121 in healthy adults.

The study includes three parts:

Part A: single ascending dose.

Part B: comparison of AVAT-121 with Epidyolex(R), under fed and fasted conditions.

Part C: multiple-dose testing

Up to 44 participants will be enrolled in this study.

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: Focal Onset Seizure

Intervention: ...